Improving patient selection for immuno-oncology phase I trials: An external validation of five prognostic scores at Claudius Regaud Institute of Toulouse, Oncopôle (IUCT-O)Ghassan Al Darazi, Carlos Gomez‐Roca, Jean‐Pierre Delord et al.|Annals of Oncology|2019Cited by 1